In general, 15-PGDH seems to be involved in the early stages of CRC tumorigenesis but the molecular targets and signaling pathways that interact directly with 15-PGDH in CRC therapy require further investigation to be fully understood. Here, HPGD is linked to colorectal carcinoma.